Rhythm Pharmaceuticals

Quarterly Financials

Values in thousands2026-03-312025-12-312025-09-302025-06-30
Revenue
$60,112
$57,253
$51,298
$48,502
Gross Profit
52,955
52,451
45,799
42,959
EBITDA
-50,259
-42,649
-47,747
-40,099
EBIT
-50,511
-42,921
-48,051
-40,478
Net Income
-55,639
-47,505
-52,904
-46,632
Net Change In Cash
60,112
57,253
51,298
48,502
Free Cash Flow
-44,185
-26,342
-26,622
-23,313
Cash
62,137
54,301
52,078
135,586
Basic Shares
67,974
66,876
64,346
63,684

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$189,757
$130,126
$77,428
$23,638
Gross Profit
170,265
116,758
68,126
21,505
EBITDA
-174,121
-238,090
-168,464
-174,246
EBIT
-175,459
-239,653
-170,222
-175,918
Net Income
-196,539
-260,602
-184,678
-181,119
Net Change In Cash
189,757
130,126
77,428
23,638
Cost of Revenue
68,429
Free Cash Flow
-116,628
-113,879
-136,204
-177,709
Cash
54,301
89,137
60,081
127,677
Basic Shares
64,984
60,995
57,673
52,120

Earnings Calls

QuarterEPS
2026-03-31
-$0.83
2025-12-31
-$0.73
2025-09-30
-$0.82
2025-06-30
-$0.75